{"id":2970,"date":"2023-10-18T21:12:59","date_gmt":"2023-10-18T21:12:59","guid":{"rendered":"https:\/\/alfevents.org\/ariassymposium\/?page_id=2970"},"modified":"2026-06-16T13:10:57","modified_gmt":"2026-06-16T13:10:57","slug":"speaker-bios","status":"publish","type":"page","link":"https:\/\/alfevents.org\/ariassymposium\/speaker-bios\/","title":{"rendered":"Speaker Bios"},"content":{"rendered":"\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tIrwin M. Arias, MD (Founder) <\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t

\"\"<\/p>

Dr. Irwin Arias is a triple Emeritus: Professor of Medicine, Albert Einstein College of Medicine, Professor of Physiology and Medicine, Tufts University School of Medicine, and Senior Scientist at the National Institutes of Health where he continues to teach.<\/p>

He has dedicated his career to bridging the gap between scientists in the lab and medical doctors in the clinic, continually building bridges to link basic biology to human disease. In his long and continuing career in liver-related science, medicine, and education, some of his most notable accomplishments include discoveries of mechanisms of inheritable jaundice, ABC transporters mediate bile transport, and that AMP Kinase and Liver Kinase-81 regulate hepatocyte polarization, mitochondrial fusion, ATP production, and bile transporters. These research outcomes established new paradigms for biliary secretion and led to molecular identification of inheritable liver diseases.<\/p>

A founder of the American Liver Foundation (ALF) and long-term member of both the former New England Division and National Board of Directors, Dr. Arias has contributed substantially to the mission of ALF and his energy and passion for helping liver patients shows no signs of stopping. His support of young PhD and physician scientists interested in the pursuit of liver disease is nothing short of inspiring. Dr. Arias has been the recipient of many national and international honors and his course, \u201cDemystifying Medicine\u201d, which he established at the National Institutes of Health (NIH), has gained national and global attention.<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t

\n\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t
\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tIrwin M. Arias, MD (Founder) <\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t

\"\"<\/p>

Dr. Irwin Arias is a triple Emeritus: Professor of Medicine, Albert Einstein College of Medicine, Professor of Physiology and Medicine, Tufts University School of Medicine, and Senior Scientist at the National Institutes of Health where he continues to teach.<\/p>

He has dedicated his career to bridging the gap between scientists in the lab and medical doctors in the clinic, continually building bridges to link basic biology to human disease. In his long and continuing career in liver-related science, medicine, and education, some of his most notable accomplishments include discoveries of mechanisms of inheritable jaundice, ABC transporters mediate bile transport, and that AMP Kinase and Liver Kinase-81 regulate hepatocyte polarization, mitochondrial fusion, ATP production, and bile transporters. These research outcomes established new paradigms for biliary secretion and led to molecular identification of inheritable liver diseases.<\/p>

A founder of the American Liver Foundation (ALF) and long-term member of both the former New England Division and National Board of Directors, Dr. Arias has contributed substantially to the mission of ALF and his energy and passion for helping liver patients shows no signs of stopping. His support of young PhD and physician scientists interested in the pursuit of liver disease is nothing short of inspiring. Dr. Arias has been the recipient of many national and international honors and his course, \u201cDemystifying Medicine\u201d, which he established at the National Institutes of Health (NIH), has gained national and global attention.<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t

\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tFrancis Collins, MD, PhD, NIH Distinguished Investigator, Center for Precision Health Research, National Institute of Health <\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t

\"\"Dr. Francis Collins is a physician-scientist. Under his direction, the Human Genome Project produced the first finished sequence of the human DNA instruction book in 2003. \u00a0From 2009 to 2021, Collins served under three Presidents as the Director of the U.S. National Institutes of Health, the largest supporter of biomedical research in the world.\u00a0 Following a year in the White House as the President\u2019s Acting Science Advisor, he oversees a research laboratory as a Distinguished Investigator in the intramural program of the National Human Genome Research Institute.\u00a0 He also leads a bold administration initiative to eliminate hepatitis C in the United States.\u00a0 His contributions to science, medicine, and society have been recognized by the Presidential Medal of Freedom, the National Medal of Science, and the Templeton Prize.\u00a0 His most recent book is The Road To Wisdom: On Truth, Science, Faith, and Trust\u00a0(Little Brown and Worthy, 2024).\u00a0<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t

\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tFernando Camargo, PhD, Professor of Stem Cell and Regenerative Biology, Boston Children's Hospital, Boston, MA<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t

\"\"<\/p>

Dr. Camargo joined the Children’s Hospital and the Stem Cell and Regenerative Biology Department at Harvard University in 2009. Dr. Camargo was named a 2009 V Foundation Scholar and is the recipient of the NIH Director\u2019s New Innovator Award. Most recently, he has received the Vilcek Prize for Creative Promise in Biomedical Science and the ISSCR\u2019s Dr. Susan Lim Award for Outstanding Young Investigator. In February 2022, Dr. Camargo was named the first Regenerative Biology Endowed Chair, in recognition of his scientific contributions and strong leadership.<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t

\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tAnne Carpenter, PhD, Senior Director of the Imaging Platform, Institute Scientist, Broad Institute of MIT and Harvard<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t

\"\"Dr. Carpenter is an Institute Scientist at the Broad Institute of Harvard and MIT. Her research group develops algorithms and strategies for large-scale experiments involving images. The team\u2019s open-source CellProfiler software is used by thousands of biologists worldwide and their Cell Painting assay has been adopted throughout the pharma industry to accelerate drug discovery. She leads industry-wide consortia such as JUMP-Cell Painting and OASIS.\u00a0<\/p>

Her PhD is in cell biology from the University of Illinois, Urbana-Champaign. Her postdoc in high-throughput image analysis was at the Whitehead Institute for Biomedical Research and MIT\u2019s CSAIL (Computer Sciences\/Artificial Intelligence Laboratory). Carpenter has been named an NSF CAREER awardee, an NIH MIRA awardee, and is listed in Deep Knowledge Analytics\u2019 top-100 AI Leaders in Drug Discovery and Advanced Healthcare.\u00a0<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t

\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tKwanghun (KC) Chung, PhD, Associate Professor of Chemical Engineering, Institute for Medical Engineering & Science, Massachusetts Institute of Technology<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t

\"\"Dr. Kwanghun Chung is currently an Associate Professor of Chemical Engineering at MIT, as well as a Core Member of the Institute for Medical Engineering and Science (IMES). He is also a Core Member of the Picower Institute for Learning and Memory, and an Associate Member of the Broad Institute. He received his B.S. in Chemical Engineering from Seoul National University in 2005, and then moved to Georgia Institute of Technology for his Ph.D. training under the mentorship of Dr. Hang Lu, where he developed automated and integrated microsystems for high-throughput imaging, molecular\/behavioral phenotyping, and cell microsurgery of a broad range of living systems. Following his graduation in 2009, Dr. Chung joined the Karl Deisseroth Lab at Stanford University for post-doctoral training in 2010, where he invented a novel technology termed CLARITY (Chung, Nature, 2013), which enables system-wide structural and molecular analysis of large-scale intact biological samples. In 2013, Dr. Chung joined MIT and has been leading an interdisciplinary team to develop and apply novel methods for holistic understanding of large-scale complex biological systems. His group has developed a host of technologies (SWITCH [Cell, 2015], Stochastic Electrotransport [PNAS, 2015], MAP [Nature Biotechnology, 2016], SHIELD [Nature Biotechnology, 2019], and ELAST [Nature Methods, 2020]) that enable rapid and scalable 3D imaging and phenotyping of both animal models and human clinical samples. He cofounded LifeCanvas Technologies to commercialize his inventions, which has enabled rapid adoption of the technologies by over 400 labs and core facilities in leading institutions, and companies across 14 countries. Chung was the recipient of the Presidential Early Career Award for Scientists and Engineers (PECASE) 2019, the NIH New Innovator Award 2016, the Mcknight Technological Innovations in Neuroscience Award 2016, the Packard Fellowships for Science and Engineering Award 2015, the NARSAD Young Investigator Award 2015, the Yumin Awards for Creativity 2014, the Searle Scholars Award 2014, and the BWF Career Award at the Scientific Interface 2012.\u00a0\u00a0<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t

\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tUdeme Ekong, MD, MPH, FAASLD, Associate Professor, Department of Surgery and Pediatrics, Georgetown University<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t

\"\"<\/p>

Dr Ekong is a professor of pediatrics and surgery at Georgetown University School of Medicine, Washington, DC, and an attending physician in pediatric transplant hepatology at MedStar Georgetown University, Hospital, Washington, DC.<\/p>

Dr Ekong attended medical school in Nigeria and proceeded to the United Kingdom and United States for residency and fellowship training in pediatrics, pediatric gastroenterology, and pediatric transplant hepatology.<\/p>

In addition to her clinical work, Dr Ekong is an active researcher.<\/p>

The Ekong laboratory interest is in mechanisms that underlie regulatory T cell dysfunction in autoimmune and alloimmune liver disease after liver transplantation. Inflammasome activation, Human Endogenous Retrovirus reactivation, Endoplasmic Reticulum stress with unfolded protein response activation contribute to regulatory T cell dysfunction, so a major focus of the laboratory is to understand these phenomena in molecular terms. The Ekong laboratory has a strong history of collaborative work with key collaborations with laboratories at the NIH, Yale University, Columbia University, and Imperial College, London, UK.<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t

\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tLijian Hui, PhD, Distinguished Adjunct Professor, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t

\"\"<\/p>

Dr. Lijian Hui<\/strong> is the PI in Shanghai Institute of Biochemistry and Cell Biology (SIBCB). He is currently the Assistant Director of SIBCB , board member of Chinese Association of Cell Biology, President of Chinese Association of Cell and Gene Therapy, editorial board member of Cell Stem Cell, Hepatology etc.<\/p>

Dr. Hui studies molecular pathology of liver diseases, with the focus on cell identity conversion, i.e., dedifferentiation and transdifferentiation, in liver regeneration and tumorigenesis. His team demonstrated the conversion from fibroblasts into hepatocytes in vitro, thereby providing one of the first evidence of transdifferentiation in mammalian cells. His team is also among the first to report cell identity conversion in liverinjury and repair. Based on these fundamental findings, his team generates functional hepatocytes, hiHep and ProliHH, for clinical application. Innovative therapies based on these cells, namely bioartificial liver devices and encapsulated liver organoids, are now being tested in clinics. Dr. Hui is also the founder of Hexaell Biotech, which aims to helping liver disease patients with edge-cutting cell therapy technologies.<\/p>

Dr. Hui has recieved several awards, including 10 Top Breakthroughs in Science and Technology of China, China Young Scientists Award, Natural Science Award of Shanghai Municipality, Tan Jiazhen Life Science Innovation Award etc.<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t

\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tKristin Knouse, MD, PhD, Whitehead Career Development Professor, Department of Biology and Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t

\"\"Dr Kristin Knouse is the Whitehead Career Development Professor in the MIT Department of Biology and the Koch Institute for Integrative Cancer Research. She received a B.S. in biology from Duke University in 2010 and then enrolled in the Harvard and Massachusetts Institute of Technology (MIT) M.D.-Ph.D. Program, where she earned a Ph.D. through the MIT Department of Biology in 2016 and an M.D. through the Harvard-MIT Division of Health Sciences and Technology in 2018. She conducted her doctoral research in the laboratory of Angelika Amon, where she developed tools to characterize large-scale somatic copy number alterations in mammalian tissues and then used diverse approaches to reveal the importance of tissue architecture for chromosome segregation fidelity in epithelia. In 2018, she established her laboratory as a Whitehead Fellow at the Whitehead Institute for Biomedical Research and was honored with the NIH Director\u2019s Early Independence Award. In July 2021, she joined the MIT Department of Biology and Koch Institute for Integrative Cancer Research as an Assistant Professor. Her lab develops high-throughput functional genomics approaches to understand and modulate organ injury and regeneration.<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t

\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tMiriam Merad, MD, PhD, Professor and Chair, Department of Immunology and Immunotherapy, Mount Sinai School of Medicine, New York, NY<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t

\"\"<\/p>

\u00a0<\/p>

Dr. Merad is an internationally acclaimed physician-scientist and a leader in the fields of dendritic cell and macrophage biology with a focus on their contribution to human diseases. Dr. Merad identified the tissue resident macrophage lineage and revealed its distinct role in organ physiology and pathophysiology. She established the contribution of this macrophage lineage to cancer progression and inflammatory diseases and is now working on the development of novel macrophage-targeted therapies for these conditions. In addition to her work on macrophages, Dr. Merad is known for her work on dendritic cells, a group of cells that control adaptive immunity. She identified a new subset of dendritic cells, which is now considered a key target of antiviral and antitumor immunity.<\/p>

Dr. Merad leads the Precision Immunology Institute at the Icahn School of Medicine (PrIISM) to bring immunology discoveries to the clinic. She also founded the Human Immune Monitoring Center at Mount Sinai, one of the world\u2019s most sophisticated research centers, which uses cutting-edge single-cell technology to understand the contribution of immune cells to major human diseases or treatment responses.\u00a0<\/p>

Dr. Merad has authored more than 200 primary papers and reviews in high profile journals. Her work has been cited several thousand times. She receives generous funding from the National Institutes of Health (NIH) for her research on innate immunity and their contribution to human disease, and belongs to several NIH consortia.\u00a0<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t

\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tAllison F. O\u2019Neill, MD, Assistant Professor of Pediatrics, Director, Solid Tumor Program; Director, Liver Tumor Center of Excellence; Chair, Liver Tumor Committee COG; Dana-Farber Cancer Institute, Boston, MA<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t

\"\"<\/p>

Dr. Allison O\u2019Neill is a Pediatric Oncology physician-scientist with a passion for translational research and expertise in the care of pediatric patients with solid tumors.\u00a0 She serves as the Clinical Director of the Pediatric Solid Tumor Program and Medical Director of the Liver Tumor Center of Excellence at Dana-Farber Cancer Institute and Boston Children\u2019s Hospital. In her role as Director of the Solid Tumor Program, Dr. O\u2019Neill\u2019s overarching responsibilities include guiding clinical research initiatives in concert with their experimental therapeutics division and revising their current clinical care infrastructure. \u00a0Dr. O\u2019Neill is self-tasked with cultivating a programmatic mission surrounding multidisciplinary clinics, visibility in the rare tumor space, and expanding initiatives in immunotherapy. The Liver Tumor Center of Excellence collaboratively unites individuals of a broad multidisciplinary expertise to deliver care to children with these exceptionally rare tumors. Nationally, she chairs the Children\u2019s Oncology Group Liver Tumor Committee which provides a far-reaching collaborative network through which to conduct clinical trials for patients with these rare and often difficult-to-treat tumors.<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t

\n\t\t\t\t\t
\n\t\t\t\t\t\t\t\t\t\t\t\t\t\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t<\/i><\/span>\n\t\t\t\t\t\t\t\t\t\t\t\t\t\t<\/span>\n\t\t\t\t\t\t\t\t\t\t\t\tQuin Wills, MD, PhD, Founder and Chief Scientific Officer, Ochre Bio, New York, NY<\/a>\n\t\t\t\t\t<\/div>\n\t\t\t\t\t

\"\"Dr. Quin Wills is a medical doctor with further degrees in genetics, mathematics, computational biology, and a doctorate in systems genomics, from Oxford and Cambridge Universities. He started his first drug discovery liver genomics company 17 years ago. More recently he founded and led Novo Nordisk\u2019s Advanced Genomics Department, again focused on liver disease. Frustrated with the lack of therapeutic innovation in chronic diseases, Quin co-founded Ochre Bio, a liver RNA therapeutics company that differentiates itself in the ability to generate large-scale human discovery and validation data at its global R&D sites in Europe, Asia, and the US. A key innovation from Quin’s team’s at the intersection of dry-lab (machine learning) and wet-lab has been the ability to progress a hit to generating human data on the lead within weeks, not years. They do this using whole human livers that they maintain on machines.\u00a0<\/p><\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"

Irwin M. Arias, MD (Founder) Dr. Irwin Arias is a triple Emeritus: Professor of Medicine, Albert Einstein College of Medicine, Professor of Physiology and Medicine, Tufts University School of Medicine, and Senior Scientist at the National Institutes of Health where he continues to teach. He has dedicated his career to bridging the gap between scientists in the lab and medical doctors in the clinic, continually building bridges to link basic biology to human disease. In his long and continuing career in liver-related science, medicine, and education, some of his most notable accomplishments include discoveries of mechanisms of inheritable jaundice, ABC\u2026<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"class_list":["post-2970","page","type-page","status-publish","hentry"],"blocksy_meta":{"styles_descriptor":{"styles":{"desktop":"","tablet":"","mobile":""},"google_fonts":[],"version":5},"page_title_panel":"","has_hero_section":"default","5eb631037468254faccb548cafbc9d49":"","hero_section":"type-1","hero_elements":[{"id":"custom_title","enabled":true,"heading_tag":"h1","title":"Home"},{"id":"custom_description","enabled":true,"description_visibility":{"desktop":true,"tablet":true,"mobile":false}},{"id":"custom_meta","enabled":false,"meta_elements":[{"id":"author","enabled":true,"label":"By","has_author_avatar":"yes","avatar_size":25},{"id":"post_date","enabled":true,"label":"On","date_format_source":"default","date_format":"M j, Y"},{"id":"updated_date","enabled":false,"label":"On","date_format_source":"default","date_format":"M j, Y"},{"id":"categories","enabled":false,"label":"In","style":"simple"},{"id":"comments","enabled":true}],"page_meta_elements":{"joined":true,"articles_count":true,"comments":true}},{"id":"breadcrumbs","enabled":false}],"371956f0517a729e47f854a9bc7e1bf4":"","hero_alignment1":"CT_CSS_SKIP_RULE","hero_margin":40,"hero_alignment2":"center","hero_vertical_alignment":"center","18a66bc73ab56064e5ea650acedeb459":"","hero_structure":"narrow","b364491f128cb71878997c75301f5d93":"","page_title_bg_type":"featured_image","custom_hero_background":{"attachment_id":null},"page_title_image_size":"full","parallax":{"desktop":false,"tablet":false,"mobile":false},"fcb6e338f4c4856016b90fe446f2483d":"","hero_height":"250px","pageTitleFont":{"family":"Default","variation":"Default","size":"30px","line-height":"CT_CSS_SKIP_RULE","letter-spacing":"CT_CSS_SKIP_RULE","text-transform":"CT_CSS_SKIP_RULE","text-decoration":"CT_CSS_SKIP_RULE"},"pageTitleFontColor":{"default":{"color":"CT_CSS_SKIP_RULEDEFAULT"}},"pageMetaFont":{"family":"Default","variation":"n6","size":"12px","line-height":"1.3","letter-spacing":"CT_CSS_SKIP_RULE","text-transform":"uppercase","text-decoration":"CT_CSS_SKIP_RULE"},"pageMetaFontColor":{"default":{"color":"CT_CSS_SKIP_RULEDEFAULT"},"hover":{"color":"CT_CSS_SKIP_RULEDEFAULT"}},"page_meta_button_type_font_colors":{"default":{"color":"CT_CSS_SKIP_RULEDEFAULT"},"hover":{"color":"CT_CSS_SKIP_RULEDEFAULT"}},"page_meta_button_type_background_colors":{"default":{"color":"CT_CSS_SKIP_RULEDEFAULT"},"hover":{"color":"CT_CSS_SKIP_RULEDEFAULT"}},"pageExcerptFont":{"family":"Default","variation":"Default","size":"CT_CSS_SKIP_RULE","line-height":"CT_CSS_SKIP_RULE","letter-spacing":"CT_CSS_SKIP_RULE","text-transform":"CT_CSS_SKIP_RULE","text-decoration":"CT_CSS_SKIP_RULE"},"pageExcerptColor":{"default":{"color":"CT_CSS_SKIP_RULEDEFAULT"}},"breadcrumbsFont":{"family":"Default","variation":"Default","size":"CT_CSS_SKIP_RULE","line-height":"CT_CSS_SKIP_RULE","letter-spacing":"CT_CSS_SKIP_RULE","text-transform":"CT_CSS_SKIP_RULE","text-decoration":"CT_CSS_SKIP_RULE"},"breadcrumbsFontColor":{"default":{"color":"CT_CSS_SKIP_RULEDEFAULT"},"initial":{"color":"CT_CSS_SKIP_RULEDEFAULT"},"hover":{"color":"CT_CSS_SKIP_RULEDEFAULT"}},"pageTitleOverlay":{"background_type":"color","background_pattern":"type-1","background_image":{"attachment_id":null,"x":0,"y":0},"gradient":"linear-gradient(135deg,rgba(6,147,227,1) 0%,rgb(155,81,224) 100%)","background_repeat":"repeat","background_size":"auto","background_attachment":"scroll","patternColor":{"default":{"color":"#e5e7ea"}},"overlayColor":{"default":{"color":"CT_CSS_SKIP_RULE"}},"backgroundColor":{"default":{"color":"CT_CSS_SKIP_RULE"}}},"pageTitleBackground":{"background_type":"color","background_pattern":"type-1","background_image":{"attachment_id":null,"x":0,"y":0},"gradient":"linear-gradient(135deg,rgba(6,147,227,1) 0%,rgb(155,81,224) 100%)","background_repeat":"repeat","background_size":"auto","background_attachment":"scroll","patternColor":{"default":{"color":"#e5e7ea"}},"overlayColor":{"default":{"color":"CT_CSS_SKIP_RULE"}},"backgroundColor":{"default":{"color":"var(--paletteColor6)"}}},"pageTitlePadding":{"top":"50px","bottom":"50px","left":"auto","right":"auto","linked":true},"787d55b9fa196b342893c1093ba8766e":"","page_structure_type":"type-1","03205635f5df1c48846ede0ccb2c4fbe":"","content_style_source":"inherit","content_style":"wide","vertical_spacing_source":"inherit","content_area_spacing":"both","background":{"background_type":"color","background_pattern":"type-1","background_image":{"attachment_id":null,"x":0,"y":0},"gradient":"linear-gradient(135deg,rgba(6,147,227,1) 0%,rgb(155,81,224) 100%)","background_repeat":"repeat","background_size":"auto","background_attachment":"scroll","patternColor":{"default":{"color":"#e5e7ea"}},"overlayColor":{"default":{"color":"CT_CSS_SKIP_RULE"}},"backgroundColor":{"default":{"color":"CT_CSS_SKIP_RULE"}}},"content_background":{"background_type":"color","background_pattern":"type-1","background_image":{"attachment_id":null,"x":0,"y":0},"gradient":"linear-gradient(135deg,rgba(6,147,227,1) 0%,rgb(155,81,224) 100%)","background_repeat":"repeat","background_size":"auto","background_attachment":"scroll","patternColor":{"default":{"color":"#e5e7ea"}},"overlayColor":{"default":{"color":"CT_CSS_SKIP_RULE"}},"backgroundColor":{"default":{"color":"var(--paletteColor8)"}}},"content_boxed_shadow":{"inherit":false,"blur":18,"spread":-6,"v_offset":12,"h_offset":0,"inset":false,"enable":true,"color":{"color":"rgba(34, 56, 101, 0.04)"}},"content_boxed_border":{"width":1,"style":"none","color":{"color":"rgba(44,62,80,0.2)"}},"content_boxed_radius":{"top":"3px","bottom":"3px","left":"3px","right":"3px","linked":true},"boxed_content_spacing":{"desktop":{"top":"40px","bottom":"40px","left":"40px","right":"40px","linked":true},"tablet":{"top":"35px","bottom":"35px","left":"35px","right":"35px","linked":true},"mobile":{"top":"20px","bottom":"20px","left":"20px","right":"20px","linked":true}},"8b3053610d6f050b3ee539aebd47261d":"","disable_featured_image":"no","disable_share_box":"no","disable_header":"no","disable_footer":"no","3f750eda2a5ab89fc76bb92127d2767b":"","header_footer_scripts_panel":"","header_scripts":"","d874aede2c9123a9b1a2a30fc95e6f77":"","header_after_body_scripts":"","f76050a1185baacd630c3233a3e6b385":"","footer_scripts":""},"_links":{"self":[{"href":"https:\/\/alfevents.org\/ariassymposium\/wp-json\/wp\/v2\/pages\/2970"}],"collection":[{"href":"https:\/\/alfevents.org\/ariassymposium\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/alfevents.org\/ariassymposium\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/alfevents.org\/ariassymposium\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/alfevents.org\/ariassymposium\/wp-json\/wp\/v2\/comments?post=2970"}],"version-history":[{"count":84,"href":"https:\/\/alfevents.org\/ariassymposium\/wp-json\/wp\/v2\/pages\/2970\/revisions"}],"predecessor-version":[{"id":3465,"href":"https:\/\/alfevents.org\/ariassymposium\/wp-json\/wp\/v2\/pages\/2970\/revisions\/3465"}],"wp:attachment":[{"href":"https:\/\/alfevents.org\/ariassymposium\/wp-json\/wp\/v2\/media?parent=2970"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}